Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Income from Continuing Operations (2017 - 2025)

Historic Income from Continuing Operations for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to -$1.6 million.

  • Lexaria Bioscience's Income from Continuing Operations rose 4144.97% to -$1.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$10.8 million, marking a year-over-year decrease of 4747.72%. This contributed to the annual value of -$11.9 million for FY2025, which is 10697.15% down from last year.
  • Latest data reveals that Lexaria Bioscience reported Income from Continuing Operations of -$1.6 million as of Q4 2025, which was up 4144.97% from -$2.7 million recorded in Q3 2025.
  • Over the past 5 years, Lexaria Bioscience's Income from Continuing Operations peaked at -$668006.0 during Q1 2024, and registered a low of -$3.8 million during Q2 2025.
  • Over the past 5 years, Lexaria Bioscience's median Income from Continuing Operations value was -$1.7 million (recorded in 2024), while the average stood at -$1.9 million.
  • As far as peak fluctuations go, Lexaria Bioscience's Income from Continuing Operations surged by 4953.21% in 2024, and later tumbled by 31182.44% in 2025.
  • Over the past 5 years, Lexaria Bioscience's Income from Continuing Operations (Quarter) stood at -$2.0 million in 2021, then grew by 15.38% to -$1.7 million in 2022, then surged by 33.24% to -$1.1 million in 2023, then crashed by 137.73% to -$2.7 million in 2024, then surged by 41.45% to -$1.6 million in 2025.
  • Its Income from Continuing Operations was -$1.6 million in Q4 2025, compared to -$2.7 million in Q3 2025 and -$3.8 million in Q2 2025.